- Business Wire•yesterday
BIOLASE, Inc. , the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, May 3, 2017, at 4:30 p.m. Eastern Time to discuss its operating results for its first quarter ended March 31, 2017, and to answer questions.
- Business Wire•14 days ago
BIOLASE, Inc. , the global leader in dental lasers, announced today that investors including Oracle Partners, L.P., Oracle Ten Fund Master, L.P. and Oracle Institutional Partners L.P., the Schuler Family Foundation, and certain BIOLASE directors and officers, have agreed to purchase $10.0 million of unregistered shares of the Company’s convertible preferred stock and $0.5 million of warrants to purchase ...
- Business Wire•last month
BIOLASE, Inc. , the global leader in dental lasers, today announced that on March 27, 2017, Mark J. Nelson, the Company’s newly hired Senior Vice President and Chief Financial Officer, received options to purchase 600,000 shares of the Company’s common stock with an exercise price of $1.28 per share, the closing price per share on March 27, 2017.
BIOL : Summary for Biolase, Inc. - Yahoo Finance
BIOLASE, Inc. (BIOL)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.38 x 400|
|Ask||1.41 x 7900|
|Day's Range||1.35 - 1.44|
|52 Week Range||0.80 - 1.98|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.76|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|